Aquestive Therapeutics, Inc. (AQST)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.21
-0.12%
Mkt Cap $390.27M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$9.00
Range $6.00 – $12.00
Implied Upside
+114.0%
Consensus $9.00 vs current $4.21